Should GDMT be prioritized over revascularization in new onset HFrEF? Potential lessons from the REVIVED-BCIS2 and STRONG-HF trials

Overview of attention for article published in Frontiers in Cardiovascular Medicine, June 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 57 X posts from 50 X users, with an upper bound of 184,685 followers.

RT @gbiondizoccai: CABG remains the only means of revascularization in ischemic cardiomyopathy to ⬇️ morbidity and mortality. However, defe…

RT @ZHeart11768530: 🔴 New onset HFrEF: GDMT or revascularization? 👉Initial non-invasive ischemic evaluation could better facilitate GDMT…

RT @ZHeart11768530: 🔴 New onset HFrEF: GDMT or revascularization? 👉Initial non-invasive ischemic evaluation could better facilitate GDMT…

RT @ZHeart11768530: 🔴 New onset HFrEF: GDMT or revascularization? 👉Initial non-invasive ischemic evaluation could better facilitate GDMT…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 53 additional X posts.